Healthcare Sector Report

Biogen is starting to pick up. Just today it was upgraded from BWS Financial from hold to buy. That being the case, although the last few weeks the stock has looked sluggish and has been going down, I feel that we need to hold on to this stock for a little longer. Currently it is up at 43.99 at mid-day. Last Tuesday BIIB's earnings were released and looking at the income it has declined from the beginning of the year due to its new product for MS.